308430 — Cellbion Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Cellbion Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,747	5,412	7,370	29,259
Net Total Accounts Receivable
Net Total Receivables	27.4	237	417	497
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11,654	7,563	9,001	31,571
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,366	1,603	1,420	956
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	13,851	10,037	11,346	34,408
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,635	5,277	1,537	1,067
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	5,378	7,299	3,848	4,833
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity	8,472	2,738	7,497	29,575
Total Liabilities & Shareholders' Equity	13,851	10,037	11,346	34,408
Total Common Shares Outstanding